NDC 58198-0021-5 - Baytril

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
58198-0021
Requested NDC
58198-0021-5
Package NDCs from labels
58198-0021-3, 58198-0021-1, 58198-0021-4, 58198-0021-2, 58198-0021-5
Manufacturer
Elanco US Inc.
Effective date
2026-05-07
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Elanco ™ Baytril TM 100Elanco US Inc.2026-05-07PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58198-0021-1Baytril1 in 1 CARTONINJECTION, SOLUTION16
58198-0021-2Baytril1 in 1 CARTONINJECTION, SOLUTION16
58198-0021-3Baytril100 mL in 1 BOTTLEINJECTION, SOLUTION1006
58198-0021-4Baytril250 mL in 1 BOTTLEINJECTION, SOLUTION2506
58198-0021-5Baytril500 mL in 1 BOTTLEINJECTION, SOLUTION5006

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
58198-0021BAYTRIL (ENROFLOXACIN) INJECTION, SOLUTION [ELANCO US INC.]45 package rows20250206_258967db-9587-4c19-b846-ac143dada99a.zip

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.